Mechanism of action of antileukemic agents: inhibition of DNA polymerases.
D000818:Animals; D002417:Cattle; D003561:Cytarabine / Q000627:therapeutic use; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors; D003630:Daunorubicin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006151:Guanosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy*; D019384:Nucleic Acid Synthesis Inhibitors; D013872:Thionucleosides / Q000627:therapeutic use
D019384:Nucleic Acid Synthesis Inhibitors; D013872:Thionucleosides; D003561:Cytarabine; D006151:Guanosine; D004317:Doxorubicin; C005783:6-thioguanosine; D004256:DNA Polymerase I; D004257:DNA Polymerase II; D003630:Daunorubicin